Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 386

1.

Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment.

Borderi M, Angarano G, Antinori A, Chirianni A, Cinque P, D'Arminio Monforte A, Di Biagio A, Di Perri G, Galli M, Gori A, Lazzarin A, Mussini C, Perno CF, Quirino T, Rizzardini G, Calza L, Viale P, Acone B, Andreoni M.

New Microbiol. 2018 Apr;41(2):112-117.

2.

Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia.

Calza L, Colangeli V, Borderi M, Manfredi R, Marconi L, Bon I, Re MC, Viale P.

HIV Clin Trials. 2018 Jun;19(3):120-128. doi: 10.1080/15284336.2018.1468676.

PMID:
29770749
3.

Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.

Bagella P, De Socio GV, Ricci E, Menzaghi B, Martinelli C, Squillace N, Maggi P, Orofino G, Calza L, Carenzi L, Celesia BM, Penco G, Di Biagio A, Valsecchi L, Vichi F, Colombo V, Parruti G, Dentone C, Falasca K, Bonfanti P, Madeddu G; C.I.S.A.I. Study Group, Italy.

Infect Drug Resist. 2018 Apr 26;11:615-623. doi: 10.2147/IDR.S152090. eCollection 2018.

4.

Thyroid Hormone and the White Matter of the Central Nervous System: From Development to Repair.

Calzà L, Baldassarro VA, Fernandez M, Giuliani A, Lorenzini L, Giardino L.

Vitam Horm. 2018;106:253-281. doi: 10.1016/bs.vh.2017.04.003. Epub 2017 Jun 12.

PMID:
29407438
5.

In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.

Giuliani A, Balducci AG, Zironi E, Colombo G, Bortolotti F, Lorenzini L, Galligioni V, Pagliuca G, Scagliarini A, Calzà L, Sonvico F.

Drug Deliv. 2018 Nov;25(1):376-387. doi: 10.1080/10717544.2018.1428242.

PMID:
29382237
6.

Growth and Neurotrophic Factors in Embryonic Stem Cells.

Pannella M, Giardino L, Calzà L, Fernández M.

Methods Mol Biol. 2018;1727:275-294. doi: 10.1007/978-1-4939-7571-6_21.

PMID:
29222789
7.

Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients.

Bon I, Calza L, Musumeci G, Longo S, Bertoldi A, D'Urbano V, Gibellini D, Magistrelli E, Viale PL, Re MC.

Curr HIV Res. 2017;15(6):448-455. doi: 10.2174/1570162X16666171206121026.

8.

Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy.

Calza L, Cafaggi M, Colangeli V, Borderi M, Barchi E, Lanzafame M, Nicole' S, Degli Antoni AM, Bon I, Re MC, Viale P.

Infect Dis (Lond). 2018 May;50(5):352-360. doi: 10.1080/23744235.2017.1410285. Epub 2017 Dec 6.

PMID:
29210336
9.

Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).

Calza L, Magistrelli E, Colangeli V, Borderi M, Bussini L, Bon I, Re MC, Viale P.

Infect Dis (Lond). 2017 Oct;49(10):737-747. doi: 10.1080/23744235.2017.1339325. Epub 2017 Jul 6.

PMID:
28683645
10.

Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it?

Grigioni F, Calza L.

Eur J Prev Cardiol. 2017 Sep;24(13):1381-1382. doi: 10.1177/2047487317717066. Epub 2017 Jun 23. No abstract available.

PMID:
28644094
11.

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.

Squillace N, Ricci E, Quirino T, Gori A, Bandera A, Carenzi L, De Socio GV, Orofino G, Martinelli C, Madeddu G, Rusconi S, Maggi P, Celesia BM, Cordier L, Vichi F, Calza L, Falasca K, Di Biagio A, Pellicanò GF, Bonfanti P; CISAI Study Group.

PLoS One. 2017 Jun 20;12(6):e0179254. doi: 10.1371/journal.pone.0179254. eCollection 2017.

12.

PARP activity and inhibition in fetal and adult oligodendrocyte precursor cells: Effect on cell survival and differentiation.

Baldassarro VA, Marchesini A, Giardino L, Calzà L.

Stem Cell Res. 2017 Jul;22:54-60. doi: 10.1016/j.scr.2017.05.011. Epub 2017 May 30.

13.

Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment.

Calza L, Colangeli V, Magistrelli E, Rossi N, Rosselli Del Turco E, Bussini L, Borderi M, Viale P.

HIV Clin Trials. 2017 May;18(3):110-117. doi: 10.1080/15284336.2017.1311502. Epub 2017 Apr 19.

PMID:
28420298
14.

Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings.

Cucchetto G, Lanzafame M, Nicolè S, Lattuada E, Calza L, Concia E.

J Antimicrob Chemother. 2017 Jul 1;72(7):2138-2140. doi: 10.1093/jac/dkx106. No abstract available.

PMID:
28419270
15.

Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.

Stagni F, Raspanti A, Giacomini A, Guidi S, Emili M, Ciani E, Giuliani A, Bighinati A, Calzà L, Magistretti J, Bartesaghi R.

Neurobiol Dis. 2017 Jul;103:11-23. doi: 10.1016/j.nbd.2017.03.012. Epub 2017 Mar 28.

16.

Vulnerability of primary neurons derived from Tg2576 Alzheimer mice to oxygen and glucose deprivation: role of intraneuronal amyloid-β accumulation and astrocytes.

Baldassarro VA, Marchesini A, Giardino L, Calzà L.

Dis Model Mech. 2017 May 1;10(5):671-678. doi: 10.1242/dmm.028001. Epub 2017 Feb 24.

17.

HIV and kidney: a dangerous liaison.

Bertoldi A, De Crignis E, Miserocchi A, Bon I, Musumeci G, Longo S, D'Urbano V, La Manna G, Calza L, Re MC.

New Microbiol. 2017 Jan;40(1):1-10. Review.

18.

Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.

Calza L, Colangeli V, Magistrelli E, Bussini L, Conti M, Ramazzotti E, Mancini R, Viale P.

HIV Med. 2017 Aug;18(7):474-481. doi: 10.1111/hiv.12478. Epub 2017 Jan 24.

PMID:
28116848
19.

Dual Raltegravir-Etravirine Combination as Maintenance Regimen in Virologically Suppressed HIV-1-Infected Patients.

Calza L, Magistrelli E, Colangeli V, Manfredi R, Borderi M, Rossi N, Conti M, Mancini R, Viale P.

AIDS Res Hum Retroviruses. 2017 Jul;33(7):632-638. doi: 10.1089/AID.2016.0291. Epub 2017 Feb 16.

PMID:
28088884
20.

Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.

Calza L, Magistrelli E, Colangeli V, Borderi M, Contadini I, Bon I, Re MC, Viale P.

AIDS. 2017 Mar 13;31(5):681-688. doi: 10.1097/QAD.0000000000001397.

PMID:
28060020
21.

Erratum: REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer's disease mouse model.

Lorenzini L, Giuliani A, Sivilia S, Baldassarro VA, Fernandez M, Margotti ML, Giardino L, Fontani V, Rinaldi S, Calzà L.

Sci Rep. 2016 Nov 18;6:37483. doi: 10.1038/srep37483. No abstract available.

23.

REAC technology modifies pathological neuroinflammation and motor behaviour in an Alzheimer's disease mouse model.

Lorenzini L, Giuliani A, Sivilia S, Baldassarro VA, Fernandez M, Lotti Margotti M, Giardino L, Fontani V, Rinaldi S, Calzà L.

Sci Rep. 2016 Oct 24;6:35719. doi: 10.1038/srep35719. Erratum in: Sci Rep. 2016 Nov 18;6:37483.

24.

HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): a three year study.

Musumeci G, Magnani G, Bon I, Longo S, Bertoldi A, Degli Antoni AM, Rossi MR, Ruggeri A, Sambri V, Semprini S, Sighinolfi L, Ursitti MA, Zerbini A, Colangeli V, Calza L, Finarelli AC, Massimiliani E, Re MC.

New Microbiol. 2016 Oct;39(4):241-246. Epub 2016 Sep 13.

25.

Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy.

Calza L, Colangeli V, Magistrelli E, Contadini I, Bon I, Re MC, Conti M, Mancini R, Viale P.

AIDS Res Hum Retroviruses. 2017 Feb;33(2):126-132. doi: 10.1089/AID.2016.0134. Epub 2016 Oct 14.

PMID:
27618139
26.

Affinity of (nat/68)Ga-Labelled Curcumin and Curcuminoid Complexes for β-Amyloid Plaques: Towards the Development of New Metal-Curcumin Based Radiotracers.

Rubagotti S, Croci S, Ferrari E, Iori M, Capponi PC, Lorenzini L, Calzà L, Versari A, Asti M.

Int J Mol Sci. 2016 Sep 6;17(9). pii: E1480. doi: 10.3390/ijms17091480.

27.

In Vitro Testing of Biomaterials for Neural Repair: Focus on Cellular Systems and High-Content Analysis.

Baldassarro VA, Dolci LS, Mangano C, Giardino L, Gualandi C, Focarete ML, Calzà L.

Biores Open Access. 2016 Aug 1;5(1):201-11. doi: 10.1089/biores.2016.0025. eCollection 2016.

28.

HIV Infection and Myocardial Infarction.

Calza L.

Curr HIV Res. 2016;14(6):456-465. Review.

PMID:
27492726
29.

Inflammation severely alters thyroid hormone signaling in the central nervous system during experimental allergic encephalomyelitis in rat: Direct impact on OPCs differentiation failure.

Fernández M, Baldassarro VA, Sivilia S, Giardino L, Calzà L.

Glia. 2016 Sep;64(9):1573-89. doi: 10.1002/glia.23025. Epub 2016 Jul 12.

PMID:
27404574
30.

Acute onset myopericarditis as unusual presentation of primary HIV infection.

Vandi G, Calza L, Girometti N, Manfredi R, Musumeci G, Bon I, Re MC.

Int J STD AIDS. 2017 Feb;28(2):199-201. doi: 10.1177/0956462416654852. Epub 2016 Jul 10.

PMID:
27270692
31.

CDKL5 knockout leads to altered inhibitory transmission in the cerebellum of adult mice.

Sivilia S, Mangano C, Beggiato S, Giuliani A, Torricella R, Baldassarro VA, Fernandez M, Lorenzini L, Giardino L, Borelli AC, Ferraro L, Calzà L.

Genes Brain Behav. 2016 Jun;15(5):491-502. doi: 10.1111/gbb.12292. Epub 2016 May 3.

32.

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.

De Socio GV, Ricci E, Parruti G, Calza L, Maggi P, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Penco G, Carenzi L, Franzetti M, Bonfanti P.

Infection. 2016 Oct;44(5):589-97. doi: 10.1007/s15010-016-0893-z. Epub 2016 Apr 5.

PMID:
27048184
33.

Models for preclinical studies in aging-related disorders: One is not for all.

Santulli G, Borras C, Bousquet J, Calzà L, Cano A, Illario M, Franceschi C, Liotta G, Maggio M, Molloy WD, Montuori N, O'Caoimh R, Orfila F, Rauter AP, Santoro A, Iaccarino G.

Transl Med UniSa. 2016 Jan 31;13:4-12. eCollection 2015 Dec.

34.

No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy.

Calza L, Colangeli V, Magistrelli E, Manfredi R, Bon I, Re MC, Viale P.

HIV Med. 2016 Sep;17(8):631-3. doi: 10.1111/hiv.12374. Epub 2016 Mar 29.

PMID:
27028348
35.

Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.

Calza L, Colangeli V, Manfredi R, Bon I, Re MC, Viale P.

J Antimicrob Chemother. 2016 Jun;71(6):1451-65. doi: 10.1093/jac/dkv494. Epub 2016 Feb 3. Review.

PMID:
26846208
36.

Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors.

Calza L, Danese I, Magistrelli E, Colangeli V, Manfredi R, Bon I, Re MC, Conti M, Viale P.

HIV Clin Trials. 2016 Feb;17(1):38-47. doi: 10.1080/15284336.2015.1122874. Epub 2016 Jan 5.

PMID:
26728706
37.

Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz.

Calza L, Magistrelli E, Danese I, Colangeli V, Borderi M, Bon I, Re MC, Mancini R, Conti M, Motta R, Viale P.

Curr HIV Res. 2016;14(1):61-70.

PMID:
26531764
38.

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics.

Calcagno A, Montrucchio C, Capetti A, Guaraldi G, Cenderello G, Calza L, Lanzafame M, Marinaro L, Tettoni MC, Trentini L, D'Avolio A, Di Perri G, Bonora S.

Curr HIV Res. 2016;14(1):54-60.

PMID:
26415700
39.

Improvement in renal function and bone mineral density after a switch from tenofovir/emtricitabine plus ritonavir-boosted protease inhibitor to raltegravir plus nevirapine: a pilot study.

Calza L, Magistrelli E, Colangeli V, Borderi M, Conti M, Mancini R, Viale P.

Antivir Ther. 2016;21(3):217-24. doi: 10.3851/IMP2995. Epub 2015 Sep 25.

PMID:
26405177
40.

[Non-AIDS-associated cancer disorders. A novel scenario after over thirty years from HIV discovery? Clinical experience and literature appraisal].

Manfredi R, Cascavilla A, Calza L.

Recenti Prog Med. 2015 Aug;106(8):402-6. doi: 10.1701/1960.21310. Review. Italian.

PMID:
26228863
41.

Should we screen for cognitive decline and dementia?

Calzà L, Beltrami D, Gagliardi G, Ghidoni E, Marcello N, Rossini-Favretti R, Tamburini F.

Maturitas. 2015 Sep;82(1):28-35. doi: 10.1016/j.maturitas.2015.05.013. Epub 2015 Jun 19. Review.

PMID:
26152814
42.

Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients.

Clò A, Gibellini D, Damiano D, Vescini F, Ponti C, Morini S, Miserocchi A, Musumeci G, Calza L, Colangeli V, Viale P, Re MC, Borderi M.

New Microbiol. 2015 Jul;38(3):345-56. Epub 2015 Jul 6.

43.

Role of the Thyroid System in Myelination and Neural Connectivity.

Calzà L, Fernández M, Giardino L.

Compr Physiol. 2015 Jul 1;5(3):1405-21. doi: 10.1002/cphy.c140035. Review.

PMID:
26140723
44.

In vitro differentiation of porcine aortic vascular precursor cells to endothelial and vascular smooth muscle cells.

Zaniboni A, Bernardini C, Bertocchi M, Zannoni A, Bianchi F, Avallone G, Mangano C, Sarli G, Calzà L, Bacci ML, Forni M.

Am J Physiol Cell Physiol. 2015 Sep 1;309(5):C320-31. doi: 10.1152/ajpcell.00049.2015. Epub 2015 Jul 1.

45.

Salmonella paratyphi B mycotic aneurysm of the abdominal aorta in an HIV-infected patient: a case report.

Girometti N, Giannella M, Brocchi S, Badia L, Calza L, Viale P.

Infez Med. 2015 Jun;23(2):174-7.

46.

In vitro exposure to very low-level laser modifies expression level of extracellular matrix protein RNAs and mitochondria dynamics in mouse embryonic fibroblasts.

Giuliani A, Lorenzini L, Alessandri M, Torricella R, Baldassarro VA, Giardino L, Calzà L.

BMC Complement Altern Med. 2015 Mar 24;15:78. doi: 10.1186/s12906-015-0593-8.

47.

Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.

Calza L, Danese I, Colangeli V, Manfredi R, Magistrelli E, Verucchi G, Conti M, Motta R, Viale P.

Infect Dis (Lond). 2015 Sep;47(9):625-36. doi: 10.3109/23744235.2015.1034169. Epub 2015 Apr 15.

PMID:
25875396
48.

A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues.

Manfredi R, Calza L, Marinacci G, Cascavilla A, Colangeli V, Salvadori C, Martelli G, Appolloni L, Puggioli C, Viale P.

Infez Med. 2015 Mar;23(1):36-43.

49.

Radio electric asymmetric conveyer: a novel neuromodulation technology in Alzheimer's and other neurodegenerative diseases.

Rinaldi S, Calzà L, Giardino L, Biella GE, Zippo AG, Fontani V.

Front Psychiatry. 2015 Feb 17;6:22. doi: 10.3389/fpsyt.2015.00022. eCollection 2015. Review.

50.

Raltegravir use prospectively assessed in a major HIV outpatient clinic in Italy: sample population, virological-immunological activity, and tolerability profile.

Manfredi R, Calza L, Marinacci G, Cascavilla A, Colangeli V, Salvadori C, Martelli G, Appolloni L, Puggioli C, Viale P.

Infez Med. 2014 Dec;22(4):288-95.

Supplemental Content

Support Center